(Q85014339)

English

Pharmacogenetics of oxaliplatin as adjuvant treatment in colon carcinoma: are single nucleotide polymorphisms in GSTP1, ERCC1, and ERCC2 good predictive markers?

scientific article published on 01 October 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21958378%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Pharmacogenetics of oxaliplatin as adjuvant treatment in colon carcinoma: are single nucleotide polymorphisms in GSTP1, ERCC1, and ERCC2 good predictive markers? (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21958378%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

based on heuristic

inferred from title

colon carcinoma

1 reference

based on heuristic

inferred from title

Aranzazu Fariña Sarasqueta

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21958378%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Gesina van Lijnschoten

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21958378%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Valery E P P Lemmens

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21958378%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Harm J T Rutten

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21958378%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Adriaan J C van den Brule

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21958378%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

1 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21958378%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Molecular Diagnosis and Therapy

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21958378%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

15

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21958378%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21958378%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

277-283

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21958378%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

https://scigraph.springernature.com/pub.10.1007/bf03256419

0 references

Platinum resistance: the role of DNA repair pathways

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of care for adjuvant therapy in a random population-based sample of patients diagnosed with colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gender influences treatment and survival in colorectal cancer surgery

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ERCC1 and ERCC2 polymorphisms predict clinical outcomes of oxaliplatin-based chemotherapies in gastric and colorectal cancer: a systemic review and meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ERCC1 gene polymorphism as a predictor for clinical outcome in advanced colorectal cancer patients treated with platinum-based chemotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of two human ovarian carcinoma cell lines (A2780/CP70 and MCAS) that are equally resistant to platinum, but differ at codon 118 of the ERCC1 gene

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cisplatin pharmacogenetics, DNA repair polymorphisms, and esophageal cancer outcomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gender disparities in metastatic colorectal cancer survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Molecular mechanisms of resistance and toxicity associated with platinating agents

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ERCC1 codon 118 polymorphism is a predictive factor for the tumor response to oxaliplatin/5-fluorouracil combination chemotherapy in patients with advanced colorectal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gender-specific genomic profiling in metastatic colorectal cancer patients treated with 5-fluorouracil and oxaliplatin.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacology of oxaliplatin and the use of pharmacogenomics to individualize therapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Large age and hospital-dependent variation in administration of adjuvant chemotherapy for stage III colon cancer in southern Netherlands

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Polymorphisms in Genes of Nucleotide and Base Excision Repair: Risk and Prognosis of Colorectal Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ERCC2 2251A>C genetic polymorphism was highly correlated with early relapse in high-risk stage II and stage III colorectal cancer patients: a preliminary study

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glutathione-S-transferase pi (GSTP1) codon 105 polymorphism is not associated with oxaliplatin efficacy or toxicity in advanced colorectal cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic factors in colorectal cancer. Literature review for clinical application.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

XPD polymorphisms: effects on DNA repair proficiency

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer.

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/21958378

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q85014339&oldid=2096024733"